Results 271 to 280 of about 14,106,540 (324)
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Immobilization of Ca<sup>2+</sup> by OH<sup>-</sup> ions on calcium silicate hydrates.
Casar Z +6 more
europepmc +1 more source
Strength and Impact Toughness of Multilayered 7075/1060 Aluminum Alloy Composite Laminates Prepared by Hot Rolling and Subsequent Heat Treatment. [PDF]
Zhang H +6 more
europepmc +1 more source
Polyacrylonitrile Nanofiber Mats Produced by Solution Blow Spinning: Influence of Process Parameters on Fiber Diameter and Residual Solvent Content. [PDF]
Menshutina N +3 more
europepmc +1 more source
Sustainable High Corrosion Resistance in High-Concentration NaCl Solutions for Refractory High-Entropy Alloys with High Strength and Good Plasticity. [PDF]
Chen S, Liu X, Li C, Wang W, Yue X.
europepmc +1 more source
Spiral-Grating Tapered Gold Tip Used for Micro-Nanoscale Multi-Functional Sensing. [PDF]
Huang R, Chen Y, Li ZY.
europepmc +1 more source

